Charité Research Organisation GmbH
Berlin, Germany
NCT Number: NCT01653652
The purpose of the current study is to evaluate the efficacy of administering a probiotic in adult human subjects suffering from allergic rhinitis during seasonal grass pollen exposure.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Berlin, Germany
Adult subjects with documented seasonal allergic rhinitis (SAR) to grass pollen will be assigned to placebo or probiotic groups and take either placebo or probiotic dietary intervention for 8 weeks during the grass pollen allergy season. Total nasal symptom score (TNSS) will be compared over 8 weeks between the two treatment groups.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: every day over 8 weeks
Total nasal symptom score (TNSS) measuring nasal congestion, runny nose, nasal itching and sneezing on a scale of 0-12 will be compared over 8 weeks between the two treatment groups.
Time frame: every day over 8 weeks
Time frame: every week for 8 weeks
Validated rhinoconjunctivitis quality of life questionnaire (mini RQLQ) measured weekly
Time frame: every day over 8 weeks
Time frame: every week over 8 weeks
Time frame: every week over 8 weeks
Time frame: Baseline and end of study
Société des Produits Nestlé (SPN)
Industry
Mitigation of Seasonal Allergic Rhinitis Symptoms in Adults by Probiotic Intervention
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05346718
Allergic Rhinitis, Birch Pollen Allergy
Hanover, Lower Saxony, Germany
View Trial DetailsNCT01241214
Hypersensitivity, Hypersensitivity, Immediate
Austin, Texas, United States
View Trial DetailsNCT00574379
Allergic Conjunctivitis, Conjunctival Diseases
Oklahoma City, Oklahoma, United States
View Trial DetailsNCT01280149
Hypersensitivity, Hypersensitivity, Immediate
Chicago, Illinois, United States
View Trial Details